We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
With this report you’ll gain understanding of new EU pharmacovigilance rules, from preapproval through the life of a drug, plus insight into compliance in a new era. Specifically you’ll discover:
How to deal with the PRAC
How to tailor a PRAC-ready pharmacovigilance system, including finding and appointing a new “qualified person” (QP) to oversee pharmacovigilance
How to adapt to broad new definitions of adverse drug reactions, including monitoring of off-label uses and misuses
How to prepare for safety label warning changes to accompany products whenever a regulator requests additional safety monitoring
And much more!
To receive a FREE copy of the FDAnews management report, Understanding EU Drug Safety Reporting, simply provide us with the information requested below.
You'll get immediate access to the report when you click the "submit button."